Correlation Between IPath Series and ProShares Ultra

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IPath Series and ProShares Ultra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IPath Series and ProShares Ultra into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iPath Series B and ProShares Ultra 20, you can compare the effects of market volatilities on IPath Series and ProShares Ultra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IPath Series with a short position of ProShares Ultra. Check out your portfolio center. Please also check ongoing floating volatility patterns of IPath Series and ProShares Ultra.

Diversification Opportunities for IPath Series and ProShares Ultra

IPathProSharesDiversified AwayIPathProSharesDiversified Away100%
-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between IPath and ProShares is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding iPath Series B and ProShares Ultra 20 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProShares Ultra 20 and IPath Series is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iPath Series B are associated (or correlated) with ProShares Ultra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProShares Ultra 20 has no effect on the direction of IPath Series i.e., IPath Series and ProShares Ultra go up and down completely randomly.

Pair Corralation between IPath Series and ProShares Ultra

Considering the 90-day investment horizon iPath Series B is expected to generate 1.15 times more return on investment than ProShares Ultra. However, IPath Series is 1.15 times more volatile than ProShares Ultra 20. It trades about 0.0 of its potential returns per unit of risk. ProShares Ultra 20 is currently generating about 0.0 per unit of risk. If you would invest  5,417  in iPath Series B on December 3, 2024 and sell it today you would lose (131.00) from holding iPath Series B or give up 2.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

iPath Series B  vs.  ProShares Ultra 20

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -10-50510
JavaScript chart by amCharts 3.21.15VXZ UBT
       Timeline  
iPath Series B 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in iPath Series B are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, IPath Series may actually be approaching a critical reversion point that can send shares even higher in April 2025.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar4849505152535455
ProShares Ultra 20 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ProShares Ultra 20 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, ProShares Ultra is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar1616.51717.51818.51919.520

IPath Series and ProShares Ultra Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-5.72-4.28-2.85-1.410.01.432.914.395.877.35 0.020.040.060.080.100.120.14
JavaScript chart by amCharts 3.21.15VXZ UBT
       Returns  

Pair Trading with IPath Series and ProShares Ultra

The main advantage of trading using opposite IPath Series and ProShares Ultra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IPath Series position performs unexpectedly, ProShares Ultra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProShares Ultra will offset losses from the drop in ProShares Ultra's long position.
The idea behind iPath Series B and ProShares Ultra 20 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA